Podcast 298: COPD exacerbations — 7 days of antibiotics versus 2

Podcast 298: COPD exacerbations — 7 days of a...

Up next

Podcast 301: Monkeypox — what to look for, how to treat

A VIDEO RECORDING OF THIS INTERVIEW IS AVAILABLE HERE.

This time, we look to New York for guidance on recognizing and treating monkeypox.

Dr. Eric Meyerowitz of Montefiore and Dr. Stephen Baum ...

  Show more

Podcast 300: NADIM II trial offers “quite exciting” results in lung cancer

A VIDEO RECORDING OF THIS INTERVIEW IS AVAILABLE HERE.

We’re back with another interview from this year’s IASLC conference.

This time, Christine Sadlowski and Dr. Julia Rotow interview Dr. Mar ...

  Show more

Recommended Episodes

Outpatient Antibiotic Stewardship
Mayo Clinic Talks

Host: Darryl S. Chutka, M.D. [@chutkaMD]

Guest: Kelsey L. Jensen, Pharm.D., R.Ph.

Guest: Daniel Ilges, Pharm.D., R.Ph., BCIPD

The appropriate use of antibiotics is important for a variety of reasons. It helps k ...

  Show more

Antibiotikaresistenzen: Eine interdisziplinäre Herausforderung
AMBOSS Podcast – Ärztliches Wissen für Klinik und Praxis

Antibiotikaresistenzen: Vom richtigen Umgang mit Antibiotika bis Therapien der Zukunft 

Optimal Adjuvant Chemotherapy and Targeted Therapy for Early Breast Cancer – CDK4/6 Inhibitors Rapid Update
ASCO Guidelines

Dr. Rachel Freedman and Dr. Sharon Giordano share the latest rapid guideline update from ASCO on the adjuvant use of the CDK4/6 inhibitors abemaciclib and ribociclib in patients with stage II and III breast cancer. They share details on the impetus for the update, supporting evid ...  Show more

Therapy for Stage IV NSCLC Without Driver Alterations: ASCO Living Guideline Update 2023.3 Part 1
ASCO Guidelines

Dr. Jyoti Patel and Dr. Natasha Leighl discuss the latest full update to the stage IV NSCLC without driver alterations living guideline. This guideline addresses first-, second-, and subsequent-line therapy for patients according to their histology (squamous cell and nonsquamous ...  Show more